BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Drug Development

  Novartis AG Presents New Data At WCD That Shows Significant Efficacy Of Cosentyx In Patients With Psoriasis Of The Palms, Soles Of Feet And Nails

  June 12, 2015

   · 

  11 min read
• Drug Development

  CTI BioPharma Release: Pacritinib Phase III Study Shows Positive Results In Patient Reported Outcomes Measuring Quality Of Life In Patients With Myelofibrosis

  June 12, 2015

   · 

  11 min read
• Drug Development

  Pfizer Reports Top Line Results From A Phase III Study Evaluating Desvenlafaxine Succinate Sustained-Release Formulation In Pediatric Patients With Major Depressive Disorder

  June 12, 2015

   · 

  8 min read
• Drug Development

  First Participant Dosed In Synthetic Biologics, Inc.’ Second Phase 2a Clinical Trial To Protect The Microbiome And Prevent C. difficile

  June 12, 2015

   · 

  6 min read
• Business

  New ZS Analytics And Veeva CRM Partnership Help Pharmacos Coordinate Multichannel Marketing And Sales Interactions

  June 12, 2015

   · 

  4 min read
• Drug Development

  Sunesis Pharmaceuticals, Inc. Presents New Data From VALOR Evaluating Vosaroxin In Older Patients With Acute Myeloid Leukemia At The 20th Congress Of The European Hematology Association

  June 12, 2015

   · 

  8 min read
• Symmetry Medical To Present At JMP Securities Life Sciences Conference

  June 12, 2015

   · 

  1 min read
• Business

  Elite Pharmaceuticals, Inc. To Host Conference Call And Webcast To Discuss Year End 2015 Financial Results On June 16, 2015

  June 12, 2015

   · 

  3 min read
• Verona Pharma Release: Secondary Listing To Provide Trading Facility On Xetra Exchange In Germany

  June 12, 2015

   · 

  1 min read
• Drug Development

  Ariad Announces Long-Term Safety And Efficacy Data Of Ponatinib From Phase II Pace Clinical Trial

  June 12, 2015

   · 

  16 min read